Reviews

• Androgens versus placebo or no treatment for idiopathic oligo/asthenospermia (This review has been withdrawn by the editorial group. Abstract not available)
• Antifibrinolytics for heavy menstrual bleeding (Cochrane Review)
• Barrier agents for preventing adhesions after surgery for subfertility (Cochrane Review)
• Bromocriptine for idiopathic oligo/asthenospermia (This review has been withdrawn by the editorial group. Abstract not available)
• Bromocriptine for unexplained subfertility in women (Cochrane Review)
• Cleavage stage versus blastocyst stage embryo transfer in assisted conception (Cochrane Review)
• Clomiphene citrate for ovulation induction in women with oligo-amenorrhoea (Cochrane Review)
• Clomiphene citrate for unexplained subfertility in women (Cochrane Review)
• Clomiphene or tamoxifen for idiopathic oligo/asthenospermia (This review has been withdrawn by the editorial group. Abstract not available)
• "Coasting" (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome (Cochrane Review)
• Combined oral contraceptive pill (OCP) as treatment for primary dysmenorrhoea (Cochrane Review)
• Cyclical progestogens for heavy menstrual bleeding (Cochrane Review)
• Danazol for heavy menstrual bleeding (Cochrane Review)
• Danazol for pelvic pain associated with endometriosis (Cochrane Review)
• Danazol for unexplained infertility (Cochrane Review)
• Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles (Cochrane Review)
• Embryo freezing for preventing ovarian hyperstimulation syndrome (Cochrane Review)
• Endometrial destruction techniques for heavy menstrual bleeding (Cochrane Review)
• Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding (Cochrane Review)
• Follicle-stimulating hormone and human menopausal gonadotropin for ovarian stimulation in assisted reproduction cycles (This review has been withdrawn by the editorial group. Abstract not available)
• Gonadotrophin-releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles (This review has been withdrawn by the editorial group. Abstract not available)
• Gonadotrophin-releasing hormone analogue as an adjunct to gonadotropin therapy for clomiphene-resistant polycystic ovarian syndrome (Cochrane Review)
• Gonadotrophin-releasing hormone analogues for pain associated with endometriosis (Cochrane Review)
• Gonadotrophin-releasing hormone antagonists for assisted conception (Cochrane Review)
• Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome (Cochrane Review)
• Growth hormone for in vitro fertilization (Cochrane Review)
• Herbal and dietary therapies for primary and secondary dysmenorrhoea (Cochrane Review)
• Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding (Cochrane Review)
• Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles (Cochrane Review)
• In vitro fertilisation for unexplained subfertility (Cochrane Review)
• Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome (Cochrane Review)
• Interventions for treating chronic pelvic pain in women (Cochrane Review)
• Interventions for tubal ectopic pregnancy (Cochrane Review)
• Intra-cytoplasmic sperm injection versus conventional techniques for oocyte insemination during in vitro fertilisation in patients with non-male subfertility (Cochrane Review)
• Intra-uterine versus cervical insemination of donor sperm for subfertility (Cochrane Review)
• Intra-venous albumin for preventing severe ovarian hyperstimulation syndrome (Cochrane Review)
• Kinin-enhancing drugs for unexplained subfertility in men (This review has been withdrawn by the editorial group. Abstract not available)
• Laparoscopic "drilling" by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome (Cochrane Review)
• Laparoscopic surgery for pelvic pain associated with endometriosis (Cochrane Review)
• Laparoscopic surgery for subfertility associated with endometriosis (Cochrane Review)
• Liquid and fluid agents for preventing adhesions after surgery for subfertility (Cochrane Review)
• Modern combined oral contraceptives for pain associated with endometriosis (Cochrane Review)
• Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding (Cochrane Review)
• Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution (Cochrane Review)
• Oil-soluble versus water-soluble media for assessing tubal patency with hysterosalpingography or laparoscopy in subfertile women (This review has been withdrawn by the editorial group. Abstract not available)
• Oral contraceptive pills for heavy menstrual bleeding (Cochrane Review)
• Oral oestrogen replacement therapy versus placebo for hot flushes (Cochrane Review)
• Oral versus injectable ovulation induction agents for unexplained subfertility (Cochrane Review)
• Ovulation induction with urinary follicle stimulating hormone versus human menopausal gonadotropin for clomiphene-resistant polycystic ovary syndrome (This review has been withdrawn by the editorial group. Abstract not available)
• Ovulation suppression for endometriosis (Cochrane Review)
• Postoperative procedures for improving fertility following pelvic reproductive surgery (Cochrane Review)
• Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding (Cochrane Review)
• Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids (Cochrane Review)
• Progestagens and anti-progestagens for pain associated with endometriosis (Cochrane Review)
• Progesterone/progestogen releasing intrauterine systems for heavy menstrual bleeding (Cochrane Review)
• Progestogens versus oestrogens and progestogens for irregular uterine bleeding associated with anovulation (Cochrane Review)
• Pulsatile luteinising hormone releasing hormone for ovulation induction in subfertility associated with polycystic ovary syndrome (Cochrane Review)
• Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome (Cochrane Review)
• Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles (Cochrane Review)
• Selective serotonin reuptake inhibitors for premenstrual syndrome (Cochrane Review)
• Single versus double intrauterine insemination (IUI) in stimulated cycles for subfertile couples (Cochrane Review)
• Spinal manipulation for primary and secondary dysmenorrhoea (Cochrane Review)
• Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne (Cochrane Review)
• Surgery or embolisation for varicocele in subfertile men (Cochrane Review)
• Surgery versus medical therapy for heavy menstrual bleeding (Cochrane Review)
• Surgical interruption of pelvic nerve pathways for primary and secondary dysmenorrhoea (Cochrane Review)
• Surgical treatment for tubal disease in women due to undergo in vitro fertilisation (Cochrane Review)
• Techniques for pelvic surgery in subfertility (Cochrane Review)
• Techniques for surgical retrieval of sperm prior to ICSI for azoospermia (Cochrane Review)
• Timed intercourse versus intra-uterine insemination with or without ovarian hyperstimulation for subfertility in men (Cochrane Review)
• Transcutaneous electrical nerve stimulation and acupuncture for primary dysmenorrhoea (Cochrane Review)
• Tubal flushing for subfertility (Cochrane Review)

Protocols

• Antibiotic prophylaxis for major gynaecological surgery (Cochrane Protocol)
• Anticoagulant prophylaxis for preventing thromboembolism after major gynaecological surgery (Cochrane Protocol)
• Assisted hatching for assisted conception (IVF & ICSI) (Cochrane Protocol)
• Behavioural interventions for primary and secondary dysmenorrhoea (Cochrane Protocol)
• Cycle regimes for frozen-thawed embryo transfer (Cochrane Protocol)
• Cyproterone acetate for hirsutism (Cochrane Protocol)
• Day 3 versus day 2 embryo transfer following in vitro fertilization or intracytoplasmic sperm injection (Cochrane Protocol)
• Dehydroepiandrosterone for postmenopausal women (Cochrane Protocol)
• Evening Primrose Oil or other essential fatty acids for the treatment of pre-menstrual syndrome (PMS) (Cochrane Protocol)
• Exercise for primary dysmenorrhoea (Cochrane Protocol)
• Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density (Cochrane Protocol)
• Gonadotrophin-releasing hormone analogues for hirsutism (Cochrane Protocol)
• Gonadotrophins and gonadotrophin-releasing hormone agonists for assisted reproductive technology in subfertility associated with polycystic ovary syndrome (Cochrane Protocol)
• Hormone replacement therapy for perimenopausal and postmenopausal women (Cochrane Protocol)
• Hormone replacement therapy in young women with karyotypically normal spontaneous premature ovarian failure. (Cochrane Protocol)
• Hormone replacement therapy versus placebo for menopausal symptom scores (Cochrane Protocol)
• Immune modulation therapy for autoimmune ovarian failure (Cochrane Protocol)
• In vitro fertilisation versus tubal reanastmosis (sterilisation reversal) for subfertility after tubal sterilisation (Cochrane Protocol)
• Interventions for immunological subfertility (antisperm antibodies) in men (Cochrane Protocol)
• Interventions for 'poor responders' to controlled ovarian hyperstimulation (COH) in in-vitro fertilisation (IVF) (Cochrane Protocol)
• Intra-uterine insemination for unexplained subfertility (Cochrane Protocol)
• Intra-uterine insemination versus fallopian tube sperm perfusion for non tubal infertility (Cochrane Protocol)
• Intra-uterine insemination versus timed intercourse for cervical hostility in subfertile couples (Cochrane Protocol)
• Local oestrogen for vaginal atrophy in postmenopausal women (Cochrane Protocol)
• Media and environment for culturing human oocytes and/or embryos in assisted reproduction (Cochrane Protocol)
• Nonsteroidal anti-inflammatory drugs for primary dysmenorrhoea (Cochrane Protocol)
• Number of embryos for transfer following in-vitro fertilisation or intra-cytoplasmic sperm injection (Cochrane Protocol)
• Oral agents for ovulation induction in subfertility associated with PCOS (Cochrane Protocol)
• Ovulation induction in women with spontaneous premature ovarian failure (Cochrane Protocol)
• Phytoestrogens for menopausal symptoms (Cochrane Protocol)
• Pre and post operative medical therapy for endometriosis surgery (Cochrane Protocol)
• Progesterone for premenstrual syndrome (Cochrane Protocol)
• Recombinant versus urinary human chorionic gonadotrophin for ovulation induction in assisted conception (Cochrane Protocol)
• Surgical approaches to hysterectomy for benign gynaecological disease (Cochrane Protocol)
• Surgical treatment of fibroids for subfertility (Cochrane Protocol)
• Techniques for intrauterine embryo transfer (Cochrane Protocol)
• Testosterone for postmenopausal women (Cochrane Protocol)
• Vitamin B6 for premenstrual syndrome (Cochrane Protocol)